Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

Interaction of GLP-1 and PYY3-36 in the inhibition of food intake in healthy subjects

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital, Basel, Switzerland
• Treatments: Glucagon-Like Peptide 1

Criteria

Inclusion Criteria:

• healthy male subjects

• no evidence of disease

• no history of gastrointestinal or endocrine disorders

Exclusion Criteria:

• alcohol and drug abuse

• history of gastrointestinal or endocrine disorders

• female subjects